Weenig RH, Davis MDP, Dahl PR, et al. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med. 2002;347(18):1412–8.

Article  PubMed  Google Scholar 

Haag CK, Nutan F, Cyrus JW, et al. Pyoderma gangrenosum misdiagnosis resulting in amputation: a review. J Trauma Acute Care Surg. 2019;86(2):307–13.

Article  PubMed  Google Scholar 

Haddadin OM, Erickson KM, Latour E et al. Impact of delay of diagnosis of pyoderma gangrenosum on healing outcomes and health care utilization: a prospective cohort study. J Am Acad Dermatol. 2024.

Haddadin OM, Ortega-Loayza AG, Marzano AV, et al. An approach to diagnosis and management of patients with pyoderma gangrenosum from an international perspective: results from an expert forum. Arch Dermatol Res. 2024;316(3):89.

Article  PubMed  Google Scholar 

Haag C, Hansen T, Hajar T, et al. Comparison of three diagnostic frameworks for pyoderma gangrenosum. J Invest Dermatol. 2021;141(1):59–63.

Article  CAS  PubMed  Google Scholar 

Erickson KM, Reese AM, Ortega-Loayza AG. Gap of knowledge in diagnosis of pyoderma gangrenosum in clinical specialties education. Diagnosis (Berl). 2021;8(4):421–4.

Article  PubMed  Google Scholar 

Ruiz ES, Ingram A, Landriscina A, et al. Identifying an education gap in wound care training in United States dermatology. J Drugs Dermatol. 2015;14(7):716–20.

PubMed  Google Scholar 

Orfaly VE, Reese AM, Friedman M, et al. Pyoderma gangrenosum study pilot registry: the first step to a better understanding. Wound Repair Regen. 2022;30(3):334–7.

Article  PubMed  Google Scholar 

Tang JC, Vivas A, Rey A et al,. Atypical ulcers: wound biopsy results from a university wound pathology service. Ostomy Wound Manage. 2012;58(6):20–2, 4, 6–9.

Shanmugam VK, Schilling A, Germinario A, et al. Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre. Int Wound J. 2012;9(4):403–11.

Article  PubMed  Google Scholar 

Powell FC, Schroeter AL, Su WPD et al. Pyoderma gangrenosum: a review of 86 patients. QJM Int J Med. 1985;55(2):173–86.

Sanchez IM, Lowenstein S, Johnson KA, et al. Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis. JAMA Dermatol. 2019;155(1):79–84.

Article  PubMed  Google Scholar 

Al Ghazal P, Körber A, Klode J et al. Investigation of new co-factors in 49 patients with pyoderma gangrenosum. JDDG J Deutschen Dermatol Gesellsch. 2012;10(4):251–6.

Kroshinsky D, Alloo A, Rothschild B, et al. Necrotizing Sweet syndrome: a new variant of neutrophilic dermatosis mimicking necrotizing fasciitis. J Am Acad Dermatol. 2012;67(5):945–54.

Article  PubMed  Google Scholar 

Dissemond J, Marzano AV, Hampton PJ, et al. Pyoderma gangrenosum: treatment options. Drugs. 2023;83(14):1255–67.

Article  PubMed  PubMed Central  Google Scholar 

Barry M, AlRajhi A, Aljerian K. Pyoderma gangrenosum induced by BNT162b2 COVID-19 vaccine in a healthy adult. Vaccines (Basel). 2022;10(1).

Aggarwal P. Pyoderma gangrenosum adverse event with rituximab use: a postmarketing pharmacovigilance analysis. Dermatol Ther. 2020;33(2): e13221.

Article  CAS  PubMed  Google Scholar 

Wu BC, Patel ED, Ortega-Loayza AG. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum. Br J Dermatol. 2017;177(1):72–83.

Article  CAS  PubMed  Google Scholar 

Zhou Q, Zhou S, Xiong H, et al. A case of paradoxical reactions to biologic therapy for psoriasis. Clin Cosmet Investig Dermatol. 2023;16:1493–7.

Article  PubMed  PubMed Central  Google Scholar 

Maloney N, Novoa R, Yeh JE. Chronic ulcer in a patient with essential thrombocythemia taking hydroxyurea. Dermatol Online J. 2024;30(3).

Crittenden SC, Gilbert JE, Callen JP. Hydroxyurea-induced leg ulceration in a patient with a homozygous MTHFR polymorphism misdiagnosed as pyoderma gangrenosum. JAMA Dermatol. 2014;150(7):780–1.

Article  PubMed  Google Scholar 

Al-Khazraji Y, Al-Khazraji M, Oluaderounmu O, et al. Progression of skin ulcer secondary to calciphylaxis in a patient with end-stage renal disease (ESRD) on hemodialysis and the therapeutic approach. Cureus. 2024;16(2): e55161.

PubMed  PubMed Central  Google Scholar 

Morán-Mariños C, Corcuera-Ciudad R, Velásquez-Rimachi V, et al. Systematic review of warfarin-induced skin necrosis case reports and secondary analysis of factors associated with mortality. Int J Clin Pract. 2021;75(12): e15001.

Article  PubMed  Google Scholar 

Mendiratta V, Meena AK, Verma B, et al. Insulin-induced panniculitis in a child: a rare entity. Indian J Paediatr Dermatol. 2024;25(1):43–5.

Article  Google Scholar 

Maverakis E, Marzano AV, Le ST, et al. Pyoderma gangrenosum. Nat Rev Dis Primers. 2020;6(1):81.

Article  PubMed  Google Scholar 

Nguyen KH, Miller JJ, Helm KF. Case reports and a review of the literature on ulcers mimicking pyoderma gangrenosum. Int J Dermatol. 2003;42(2):84–94.

Article  PubMed  Google Scholar 

Shakshouk H, Lehman JS, Wu B, et al. Limb amputation in patients with pyoderma gangrenosum: a multi-institutional case series. Arch Dermatol Res. 2023;315(5):1443–8.

PubMed  Google Scholar 

Ashchyan HJ, Butler DC, Nelson CA, et al. The lum. JAMA Dermatol. 2018;154(4):409–13.

Article  PubMed  PubMed Central  Google Scholar 

Binus AM, Qureshi AA, Li VW, et al. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165(6):1244–50.

Article  CAS  PubMed  Google Scholar 

O’Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol. 1978;114(7):1061–4.

Article  CAS  PubMed  Google Scholar 

Afifi L, Sanchez IM, Wallace MM, et al. Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review. J Am Acad Dermatol. 2018;78(6):1195-204.e1.

Article  PubMed  Google Scholar 

Lichter MD, Welykyj SE, Gradini R, et al. Superficial granulomafous pyoderma. Int J Dermatol. 1991;30(6):418–21.

Article  CAS  PubMed  Google Scholar 

Rick J, Strowd L, Pasieka HB et al. Calciphylaxis: Part I. Diagnosis and pathology. J Am Acad Dermatol. 2022;86(5):973–82.

Warp PV, Hauschild M, Tookes HE, et al. A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA. Res Sq. 2023.

Cano M, Daniulaityte R, Marsiglia F. Xylazine in overdose deaths and forensic drug reports in US states, 2019–2022. JAMA Network Open. 2024;7(1):e2350630-e.

Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85(8):1454–60.

Article  PubMed  Google Scholar 

Jockenhöfer F, Herberger K, Schaller J, et al. Tricenter analysis of cofactors and comorbidity in patients with pyoderma gangrenosum. J Dtsch Dermatol Ges. 2016;14(10):1023–30.

PubMed  Google Scholar 

Taylor LT, Kody S, Rios-Duarte JA, et al. Impact of diagnostic delay on patient perspectives in pyoderma gangrenosum: an online support group-based survey study. Arch Dermatol Res. 2023;315(9):2737–9.

Article  PubMed  Google Scholar 

Moelleken M, Erfurt-Berge C, Ronicke M, et al. Predilection sites of pyoderma gangrenosum: retrospective study of 170 clearly diagnosed patients. Int Wound J. 2023;20(10):4227–34.

Article  PubMed  PubMed Central  Google Scholar 

Conrad C, Trüeb RM. Pyoderma gangrenosum. J Dtsch Dermatol Ges. 2005;3(5):334–42.

Article  PubMed  Google Scholar 

Singer AJ, Tassiopoulos A, Kirsner RS. Evaluation and management of lower-extremity ulcers. N Engl J Med. 2017;377(16):1559–67.

Article  PubMed  Google Scholar 

Ruocco E, Sangiuliano S, Gravina A, et al. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009;23(9):1008–17.

Article  CAS  PubMed  Google Scholar 

Hughes AP, Jackson JM, Callen JP. Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA. 2000;284(12):1546–8.

Article  CAS  PubMed  Google Scholar